Insulin Patch Pump Market Size, Share, Growth, and Industry Analysis, By Type (Basal Insulin, Bolus Insulin & Basal-Bolus Insulin), By Application (Hospitals, Clinics & Others) and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

INSULIN PATCH PUMP MARKET REPORT OVERVIEW

The global Insulin Patch Pump Market size was USD 0.0755 billion in 2025, and the market is projected to touch USD 0.1038 billion in 2034, exhibiting a CAGR of 3.6% during the forecast period (2025–2034).

The insulin patch pump is a wearable and small pump that is non-tubed and attaches directly to the skin to administer rapid-acting insulin to regulate diabetes and is a less conspicuous and sometimes easier solution in contrast to the traditional tubed insulin pumps. They are usually made up of an insulin reservoir and a delivery system which provides continuous insulin basal infusion with user-controlled bolus doses at meals or corrections over a wireless connection with a handheld controller or smartphone application.

COVID-19 IMPACT

Market Growth Restrained by Pandemic due to Lack of Active Market Processes

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market growth and demand returning to pre-pandemic levels.

The main adverse outcomes of COVID-19 on this market concerned the lack of active market processes in 2020 due to the fact that the country-wide lockdowns and the excessive attention to the treatment of the pandemic resulted in the reduced number of new diabetes diagnoses, as well as in the reduced number of patients starting insulin pump treatment. This was added to by the effect of the global supply chain of medical devices and consumables, as this affected the production and distribution of patch pumps by the manufacturers, leading to reduced sales and revenues for the big players in the market.

LATEST TRENDS

Automated Insulin Delivery to Propel Market Growth

It is a land of change in this market, with a major shift to the Automated Insulin Delivery (AID) or closed-loop systems getting rapidly more popular, which is a wireless connection between the patch pump, which is a discreet and tubeless insulin pump, and a Continuous Glucose Monitor (CGM) and an algorithm (using AI most frequently) to automatically adjust the insulin delivery. This integration will help glycemic control and patient quality of life greatly, replicating the work of a healthy pancreas by minimizing the need for manual adjustment and reducing both hypoglycemia and hyperglycemia.

•   
•   
  

  Request a Free sample to learn more about this report

    

INSULIN PATCH PUMP MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Basal Insulin, Bolus Insulin & Basal-Bolus Insulin

• Basal-bolus insulin: is the most prevalent in the market and is expected to enjoy the biggest share of the market during the forecast period. Patch pumps of this type (such as those in Automated Insulin Delivery (AID) systems) are in high demand due to their resemblance to a normal healthy pancreas, in that they deliver both a small continuous (background) dose of insulin and discrete, user-controlled doses of insulin (bolus) with meals (or high blood sugar).

• Basal Insulin Delivery: This section has a large but less dominant market share, and its growth will be fast, especially considering its growing usage by Type 1 diabetes patients. These machines are mainly aimed at administering the slow, sustained-release basal insulin that maintains the normal level of blood glucose between meals and at night, which is an essential demand for the treatment of type 1 diabetes.

• Bolus Insulin Delivery: This is the smallest market segment, made up of simplified devices that are principally used to administer mealtime and correctional doses of insulin (bolus), usually in pre-set steps.

By Application

Based on application the market can be categorized into Hospitals, Clinics & Others

• Hospitals Segment: The hospitals segment has a strong market share within the total channel of distribution of insulin pumps and patch pumps. To illustrate, it has been reported that the hospitals and clinics segment jointly reports a considerable share of the overall market, in many cases, with the hospitals at the forefront of this segment.

• Clinics Segment: The Clinics segment (that sometimes comprises private clinics and specialized diabetes care facilities) occupies a significant and fast-increasing market portion. Though occasionally included as a specialized group of hospitals and clinics, single clinics are crucial in offering long-term specialized services to diabetes patients.

MARKET DYNAMICS

Driving Factors

Increasing Prevalence and Burden of Diabetes on the Globe to Drive the Market Advancement

One of the major driving factors of the Insulin Patch Pump Market Growth because of the Increasing Prevalence and Burden of Diabetes on the Globe. The only thing that is overwhelmingly important is the ever-growing and quick rise in the number of individuals diagnosed with diabetes in the world, especially the rising number of insulin-dependent patients. Thousands of organizations around the world estimate that there are hundreds of millions of adults with the condition, which has resulted in patients with a large and growing pool of patients that require continuous, accurate delivery of insulin. Patch pumps are a non-invasive and more comfortable and less complex substitute for multiple daily injections (MDI). With the increase of the geriatric and obese population worldwide, the two most critical demographic variables contributing to the rise in diabetes, the need to have convenient and user-friendly equipment such as patch pumps to administer insulin to control both Type 1 and more Type 2 diabetes is greatly driven.

Automation and Transfer to Automated Systems to Expand the Market

The key source of major growth is seen in the fast innovation in technology, namely the use of insulin pumps in Automated Insulin Delivery (AID) or closed-loop systems. Patch pumps are increasingly equipped with new capabilities, including a seamless wireless connection to Continuous Glucose Monitors (CGM) and being controlled by smartphone applications. These insulin infusion pumps can automatically compute and manage insulin dosages in real time by developing advanced algorithms (including Artificial Intelligence (AI)) and reducing the cognitive load on the patient and improving the time-in-range (TIR) glycemic control.

Restraining Factor

High Price and Low Reimbursement to the Market Growth

The greatest limitation to the development and large-scale implementation of this market is the high startup cost of the gadget and the continued cost of consumables (patches/pods) and supplies in addition to poor or complicated reimbursement policies in most regions. The pump of the insulin patch, and particularly the modernized automated (closed loop) type of pump, is very expensive in comparison with the old multifamily injections (MDI). The insurance coverage of these devices and their constant supplies in most healthcare systems is not always expansive and is full of strict eligibility requirements or even absent at all, thus forcing patients to bear huge out-of-pocket expenses.

Automated Insulin Delivery (AID) Systems Integration to the Market Growth

Opportunity

This market has a major growth point in the fact that it can be easily integrated with Automated Insulin Delivery (AID) or closed-loop systems, known as artificial pancreas. Using the discrete, tubeless patch pump together with a Continuous

Glucose Monitor (CGM) and a more sophisticated algorithm driven by AI, these systems are able to automatically provide or withhold basal insulin delivery (and in some highly developed systems, also correction boluses) in response to real-time blood glucose levels to keep them at optimal levels.

Low Recurring Cost and Nonuniversal Reimbursement to Challenge the Market Growth

Challenge

Although this market has a major opportunity of costing less in the initial unit than the conventional tethered pumps, a major problem of this market is its high recurrence cost because the patch pods must be discarded after every two or three days.

This requires a high volume and constant entry of supplies, which translates to a huge amount of money that may be costly to patients, especially Type 2 diabetes patients, who form the biggest growth segment, or those living in developing regions.

•   
•   
  Request a Free sample to learn more about this report

    

INSULIN PATCH PUMPR MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

• North America

North America has emerged as the most dominant region in the Insulin Patch Pump Market share because it is fueled by the high rates of diabetes, an existing healthcare system, and a high awareness of the patients and doctors concerning the use of sophisticated diabetes management devices. One of the major markets where the innovation is tested is North America, where most of the major players and manufacturers are based in the U.S. Regulatory approvals, more so those of the U.S. Food and Drug Administration (FDA), are significant milestones that tend to clear the way to commercialization of the product and subsequent introduction to the global market.

• Europe

Europe is usually the second major regional market in the world regarding insulin pumps, and it is one of the major regions in which patch pump technology is growing and gaining. Its market is bolstered by the increasing incidence of Type 1 diabetes and the availability of many manufacturers of insulin pumps around the globe and in specific regions. The market development of Europe can be described by the CE Mark for approval of the device that will enable the sale of the devices in the European Union. Nevertheless, the adoption rate has occasionally been lower than in the U.S. because of the lag in coverage of costs and reimbursement by different national healthcare insurance programmes, but this is steadily getting better, especially in pediatric care and the ability to meet consensus-based indications of pump usage.

• Asia

The Asia-Pacific market is also expected to be the fastest-growing regional market for insulin patch pumps, even though it will be starting with a lower market share than North America and Europe. This is propelled by the huge and fast-growing population of diabetics in the region (with a huge portion of the global diabetic population), the raising healthcare infrastructure, growing awareness, and increasing disposable incomes of the major markets such as China, India and Japan. In certain developing nations, expansion of the market is presently constrained by the absence of strong reimbursement guidelines and the expensive price of treatment. The market is, however, actively being enhanced through strategic alliances between international and local firms as well as growing government efforts aimed at diabetes treatment, which has elevated the availability of patch pump technology.

KEY INDUSTRY PLAYERS

Key Players Transforming the Insulin Patch Pump Landscape through Innovation and Global Strategy

The most significant industrial factor that affects this market is the high level of attention given to technological advancements and rivalry among the leading producers of medical devices. The companies are also boosting the growth of the market through their heavy investments in research and development to develop next-generation, easy-to-use devices, mainly with the focus on the development of Automated Insulin Delivery (AID) or hybrid closed-loop systems, where, in addition to the patch pump, Continuous Glucose Monitoring (CGM) and sophisticated algorithms are integrated, which may include AI/ML, to deliver automatic and personalized insulin dosing. This industrial drive seeks to provide an ergonomic, non-tubeless, and highly convenient remedy to enhancing glycemic control and patient quality of life, which effectively transforms the management of diabetes from conventional multiple daily injections (MDIs) to an advanced, wearable, and intelligent mechanism.

List Of Market Players Profiled

• Valerita (New Jersey)
• Johnson & Johnson (U.S.)
• Insulet (U.K.)
• CeQur (Switzerland)
• Medtrum Technologies (China)

INDUSTRIAL DEVELOPMENT

June 20, 2024: Insulet Corporation declared the complete business execution of its Omnipod 5 Automated Insulin Delivery System with improved sensor incorporation in the United Kingdom and the Netherlands.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis considers both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.